A Cell-Based Double Reporter Gene Splicing Assay for Therapeutic Screening in Myotonic Dystrophy Cover

.blurhash-client-img { display: none !important; }

A Cell-Based Double Reporter Gene Splicing Assay for Therapeutic Screening in Myotonic Dystrophy

The EuroBiotech Journal

Volume 7 (2023): Issue 3 (July 2023)

By: Inyang U. Udosen, Javier T. Granados and John David Brook

Open Access

|Jul 2023

Authors

Inyang U. Udosen

inyangudosen@aksu.edu.ng

Department of Genetics & Biotechnology, Akwa Ibom State University, Nigeria

Javier T. Granados

Hospital Infantil de Mexico Federico Gomez, Laboratorio de Genomica, Mexico

John David Brook

School of Life Sciences, Queen’s Medical Centre, University of Nottingham, United Kingdom

DOI: https://doi.org/10.2478/ebtj-2023-0011 | Journal eISSN: 2564-615X

Journal RSS Feed

Language: English

Page range: 155 - 164

Published on: Jul 16, 2023

Published by: European Biotechnology Thematic Network Association

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

myotonic dystrophy,

splicing assay,

chloride channel,

therapeutic screening,

transgene constructs

Related subjects:

Bioinformatics,

Life sciences, other

© 2023 Inyang U. Udosen, Javier T. Granados, John David Brook, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 7 (2023): Issue 3 (July 2023)